Beginning in 2025, the prescription drug law requires all Medicare prescription drug plans (Medicare Part D plans)—PDP and MAPD—to offer Part D enrollees the option to pay out-of-pocket prescription drug costs in the form of capped monthly payments.
CMS prohibits the use of the Medicare name, logo, or products in a misleading way. It must be clear that the entity being represented in the material is not Medicare or representing Medicare or the Federal Government.
Green Leaf – Medicare FMO Develops and Releases Proprietary Mobile Application Call Recording Solution. On May 9th, 2022, the Center for Medicare and Medicaid Services (CMS) released a new call recording requirement that applies to Medicare insurance agents. Under the new rules, all phone calls between Medicare beneficiaries and Medicare insurance agents regarding Medicare Advantage and Medicare Prescription Drug Plans MUST be recorded beginning October 1, 2022. These recording calls must be securely retained and available to be retrieved for audit purposes for a period of 10 [...]
New Rules and Regulations for the Medicare Program for 2023 Enrollments Important CMS Marketing Changes On May 9th, new rules and regulations for the Medicare Program were posted to the Federal Registrar by the Centers for Medicare & Medicaid Services (CMS). You can find them by following this LINK. Included in this posting are some new rules for marketing Medicare Advantage and Stand-Alone Prescription Drug Plans. We will disseminate additional guidance and clarifications as we receive it from carriers and CMS, especially as we approach [...]
